0
RCPath contributes to NHS England's National Cancer Plan.
Cellular pathology is crucial for cancer diagnostics.
Historical underfunding of pathology services must be addressed.
Genomic testing integration is critical for patient treatment pathways.
The committee advocates for equitable access to cancer resources.
Increased investment in cellular pathology workforce and facilities is necessary.
Pathology should enhance multidisciplinary team contributions in cancer care.
